Literature DB >> 32980706

Unusual presentation of primary myelofibrosis with spontaneous bleeding after laparoscopic adrenalectomy: A case report.

Sara Colozzi1, Benedetta Costantini2, Serena Rupoli2, Attilio Olivieri2, Monica Ortenzi3, Mario Guerrieri3.   

Abstract

INTRODUCTION: We described unusual presentation of primary myelofibrosis with spontaneous bleeding after laparoscopic adrenalectomy. This case is written following the SCARE criteria. PRESENTATION OF CASE: A 73 years old Caucasian man underwent laparoscopic right adrenalectomy for a rapidly increasing expansive mass (3.5 × 2.5 cm) of the right adrenal gland. The night of intervention, patient underwent urgent explorative laparotomy, that highlighted massive haemoperitoneum, clots in the abdomen, on the splenic side, on Morrison's space, and at the confluence between right renal vein and inferior vena cava. Surgical specimen examination showed extra-medullary myeloid proliferation of the right periadrenal tissue. DISCUSSION: Bone marrow biopsy was performed. The list of differential diagnoses included: chronic myelomonocitic leukaemia, atypical CML and primary myelofibrosis (PMF). After discharge, several results became available: conventional cytogenetics was normal, PDGFR-α, PDGFR-β and FGFR1 mutations were negative but V617 F mutation of the JAK2 gene was positive. Therefore, the final diagnosis was pre-fibrotic primary myelofibrosis according to the 2016 WHO classification, Dynamic International Prognostic Scoring System (DIPSS) plus 2 (intermediate-2).
CONCLUSION: To our knowledge, we report uncommon case of primary myelofibrosis associated with extra-medullary myeloid proliferation of the right periadrenal tissue.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Case report; Laparoscopic adrenalectomy; Primary myelofibrosis

Year:  2020        PMID: 32980706      PMCID: PMC7522583          DOI: 10.1016/j.ijscr.2020.09.100

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

Primary myelofibrosis (PMF) is a BCR-ABL1-negative myeloproliferative neoplasm characterized by anaemia, progressive splenomegaly, extramedullary haematopoiesis, bone marrow fibrosis, constitutional symptoms, leukaemic progression, and shortened survival. Constitutive activation of the Janus kinase/signal transducers and activators of transcription (JAK-STAT) pathway, and other cellular pathways downstream, lead to myeloproliferation, pro-inflammatory cytokine expression, and bone marrow remodelling [1]. Clinical presentation of this neoplasm includes typical and atypical localizations; in fact, it is found not only in bone marrow and spleen but also in extramedullary sites, soft tissues, gastrointestinal tract, genitourinary tract and others [2,3]. This case is written following the SCARE criteria [4].

Presentation of case

We described unusual presentation of PMF with spontaneous bleeding after laparoscopic adrenalectomy. A 73 years old Caucasian man underwent laparoscopic right adrenalectomy for a rapidly increasing expansive mass (3.5 × 2.5 cm) of the right adrenal gland. It was an incidental finding on a computed tomography (CT) scan performed for dyspnoea. In the previous two years, the patient had a magnetic resonance (MR) and a positron emission tomography (PET) showing an increasing lesion with morphological features suggestive for adenoma, pheochromocytoma, tuberculosis (TB), and an enlarged spleen. Blood tests excluded secreting lesion or TB infection. The list of comorbidities included hypertension on treatment with beta-blockers, benign prostatic hypertrophy treated with silodosin, chronic obstructive pulmonary disease (COPD) treated with steroids inhalers, hypothyroidism, previous appendectomy, unspecified previous surgery for head trauma. An informed consent was obtained before surgery. According to standard procedure adopted in our Center for laparoscopic adrenalectomy [5,6], an open technique was used for laparoscopic access. Abdominal cavity exploration showed blood and clots on the surface of great omentum, in absence of any source of bleeding. After trocars placement, liver was retracted and posterior peritoneum was divided on the right side of the inferior vena cava to identify the adrenal gland (Fig. 1). After coagulation of adrenal vein, gland was dissected from its attachments and removed in a specimen retrieval bag. Haemostasis was accurately controlled, two drains were placed on the side of adrenal excision and on the perisplenic side, respectively, at the end of procedure.
Fig. 1

Intraoperative visualization of periadrenal mass.

Intraoperative visualization of periadrenal mass. After surgery, the patient was admitted on post-operative intensive care unit for parameters monitoring, due to COPD. The night of intervention the patient developed hypotension not responsive to fluids administration, tachycardia, anaemia not responsive to blood transfusions. Haematic fluid was present in drains bag. The patient underwent urgent explorative laparotomy, that highlighted massive haemoperitoneum, clots in the abdomen, on the splenic side, on Morrison’s space, and at the confluence between right renal vein and inferior vena cava. No bleeding source was found. A lavage was performed with hot fluids and haemostatics were placed on the side of previous surgery. Two drains were placed under the liver and on the right adrenalectomy site. First and second intervention were performed by the same surgeon (M.G.). In the post-operative period, we observed a progressively increase of white blood cells count (WBC), until 53.000/mm3 with basophilia, monocytosis and thrombocytosis, in the absence of any foci of infection; haemoglobin (Hb) was normal and blood transfusion was unnecessary. Clotting screening was normal. Spontaneous bleeding on abdominal wall started after the second surgery and required arteriography and embolization. Due to an increase of WBC in the absence of signs and symptoms of infection, the patient was referred to haematology.

Discussion

The main differential diagnosis was chronic myeloid leukaemia (CML), but BCR-ABL1 mutation was absent (all transcripts were tested: p190, p210, p230). Following this result, a bone marrow biopsy was performed and it showed features compatible with a chronic myeloproliferative neoplasm, without excess of blasts, associated with extra-medullary myeloid proliferation of the right periadrenal tissue. A postoperative CT-scan confirmed extramedullary localization (Fig. 2).
Fig. 2

Paravertebral localization of extramedullary neoplasm.

Paravertebral localization of extramedullary neoplasm. The list of differential diagnoses included: chronic myelomonocitic leukaemia, atypical CML and primary myelofibrosis (PMF). The patient was discharged from hospital 25 days after surgery. After discharge, several results became available: conventional cytogenetics was normal, PDGFR-α, PDGFR-β and FGFR1 mutations were negative but V617F mutation of the JAK2 gene was positive. Therefore, the final diagnosis was pre-fibrotic primary myelofibrosis according to the 2016 WHO classification [7], Dynamic International Prognostic Scoring System (DIPSS) plus 2 (intermediate-2) [8]. The patient is now being treated with hydroxycarbamide, to slowly reduce the leukocytosis, and erythropoietin α 40.000 units per week. As soon as the leukocytosis will settle, he will be considered for ruxolitinib.

Conclusion

To our knowledge, we report uncommon case of primary myelofibrosis associated with extra-medullary myeloid proliferation of the right periadrenal tissue.

Declaration of Competing Interest

All authors declare no conflict of interest.

Funding

No sources of funding.

Ethical approval

Ethical approval was not required.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of written consent is available for review by the editor-in-chief of this journal on request.

Author contribution

Sara Colozzi and Benedetta Costantini: data collection and analysis; writing paper. Serena Ruppoli, Attilio Olivieri, Monica Ortenzi and Mario Guerrieri: case management. Mario Guerrieri: revision.

Registration of research studies

Not required.

Guarantor

Mario Guerrieri.

Provenance and peer review

Not commissioned, externally peer-reviewed.
  8 in total

1.  Management of adrenal incidentaloma by laparoscopic transperitoneal anterior and submesocolic approach.

Authors:  Alessandro M Paganini; Mario Guerrieri; Andrea Balla; Silvia Quaresima; Andrea M Isidori; Franco Iafrate; Giancarlo D'Ambrosio; Giovanni Lezoche; Emanuele Lezoche
Journal:  Langenbecks Arch Surg       Date:  2015-12-18       Impact factor: 3.445

2.  The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines.

Authors:  Riaz A Agha; Mimi R Borrelli; Reem Farwana; Kiron Koshy; Alexander J Fowler; Dennis P Orgill
Journal:  Int J Surg       Date:  2018-10-18       Impact factor: 6.071

3.  DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.

Authors:  Naseema Gangat; Domenica Caramazza; Rakhee Vaidya; Geeta George; Kebede Begna; Susan Schwager; Daniel Van Dyke; Curtis Hanson; Wenting Wu; Animesh Pardanani; Francisco Cervantes; Francesco Passamonti; Ayalew Tefferi
Journal:  J Clin Oncol       Date:  2010-12-13       Impact factor: 44.544

4.  Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management.

Authors:  Ayalew Tefferi
Journal:  Am J Hematol       Date:  2018-10-26       Impact factor: 10.047

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

6.  Two Decades of Laparoscopic Adrenalectomy: 326 Procedures in a Single-Center Experience.

Authors:  Giovanni Lezoche; Maddalena Baldarelli; Maria M Cappelletti Trombettoni; Vanessa Polenta; Monica Ortenzi; Adriana Tuttolomondo; Mario Guerrieri
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2016-04       Impact factor: 1.719

7.  An unusual presentation of primary myelofibrosis.

Authors:  Prateek Tiwari; Vandana Mahajan; Kanchan Muhrerkar
Journal:  Indian J Tuberc       Date:  2017-08-03

Review 8.  Management of myelofibrosis after ruxolitinib failure.

Authors:  Claire N Harrison; Nicolaas Schaap; Ruben A Mesa
Journal:  Ann Hematol       Date:  2020-03-20       Impact factor: 3.673

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.